Last: | $231.09 |
---|---|
Change Percent: | -0.23% |
Open: | $231.27 |
Close: | $231.09 |
High: | $232.22 |
Low: | $229.04 |
Volume: | 857,068 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$231.09 | $231.27 | $231.09 | $232.22 | $229.04 | 857,068 | 07-22-2024 |
$230.74 | $235.05 | $230.74 | $235.05 | $229.45 | 1,075,022 | 07-19-2024 |
$231.74 | $231.5 | $231.74 | $235.55 | $231.49 | 1,063,279 | 07-18-2024 |
$234.05 | $230.55 | $234.05 | $235.3 | $229.765 | 1,228,449 | 07-17-2024 |
$230.7 | $226.71 | $230.7 | $230.97 | $225.4 | 1,147,619 | 07-16-2024 |
$226.08 | $229 | $226.08 | $230.77 | $225.81 | 1,260,895 | 07-15-2024 |
$229.11 | $225.5 | $229.11 | $230.34 | $224.63 | 2,220,555 | 07-12-2024 |
$224.94 | $224.58 | $224.94 | $227.46 | $224.17 | 1,849,435 | 07-11-2024 |
$223.87 | $221.41 | $223.87 | $226.62 | $218.75 | 2,109,934 | 07-10-2024 |
$221.47 | $225.24 | $221.47 | $225.7375 | $220.65 | 1,603,051 | 07-09-2024 |
$225.54 | $227.76 | $225.54 | $228.59 | $225.1907 | 826,412 | 07-08-2024 |
$227.76 | $228.68 | $227.76 | $228.68 | $225.97 | 617,155 | 07-05-2024 |
$228.84 | $228 | $228.84 | $229.32 | $227.5 | 509,817 | 07-04-2024 |
$228.84 | $228 | $228.84 | $229.32 | $227.5 | 509,817 | 07-03-2024 |
$229.24 | $229.06 | $229.24 | $231.14 | $227.69 | 662,985 | 07-02-2024 |
$229.27 | $233.76 | $229.27 | $237.705 | $229.12 | 1,057,877 | 07-01-2024 |
$233.71 | $232.27 | $233.71 | $234.84 | $230.51 | 2,404,003 | 06-28-2024 |
$230.94 | $232.28 | $230.94 | $232.98 | $229.07 | 1,471,771 | 06-27-2024 |
$231.62 | $234.055 | $231.62 | $234.61 | $230.69 | 1,695,358 | 06-26-2024 |
$233.87 | $235.28 | $233.87 | $235.51 | $233.18 | 1,028,885 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 PR Newswire FRANKLIN LAKES, N.J. , July 10 , 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1...